Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014
Study of Tumor Characteristics, Patient Care and Prognosis of Women With Breast Cancer During a Pregnancy Diagnosed Between 2000 and 2014
1 other identifier
observational
394
1 country
37
Brief Summary
This is a non-interventional, retrospective, multicentre study involving women having had a breast cancer during their pregnancy, diagnosed between 2000 and 2014 (cases) and non-pregnant women having had a breast cancer between 2000 and 2009 (controls).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2010
Longer than P75 for all trials
37 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 14, 2010
CompletedFirst Submitted
Initial submission to the registry
December 30, 2011
CompletedFirst Posted
Study publicly available on registry
January 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2015
CompletedApril 3, 2018
March 1, 2018
4.8 years
December 30, 2011
March 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival
The overall survival corresponds to the time elapsed between the breast cancer diagnostic date and the death date.
5 years
Secondary Outcomes (4)
the support of breast cancer cases occured during pregnancy
5 years
Tumor characteristics
5 years
Disease-free survival
5 years
Case-control comparison
5 years
Study Arms (2)
Study cohort
This cohort is made up of pregnant women with a breast cancer diagnosed between 2000 and 2014.
Compared cohort
This cohort is made up of non-pregnant women with a breast cancer diagnosed between 2000 and 2009.
Eligibility Criteria
This study being retrospective, we will include all the subjects that meet our inclusion criteria over the period analyzed.
You may qualify if:
- Women aged 18 or over
- Confirmed histological diagnosis of invasive breast cancer
- No known metastasis
- For the cases :
- Patients pregnant at the time of the first diagnosis
- st diagnosis between 2000 and 2014
- For the controls :
- Patients not pregnant at the time of the first diagnosis
- st diagnosis between 2000 and 2009
You may not qualify if:
- Patients who have undergone an induced abortion after the diagnosis of breast cancer
- Patients with a history of breast cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (37)
Clinique Sainte Catherine
Avignon, 84000, France
Cabinet Dr Le Guen Naas
Baud, 56150, France
Centre Hospitalier Universitaire
Besançon, 25030, France
Institut Bergonié
Bordeaux, 33076, France
CHR
Brest, 29609, France
Centre François Baclesse
Caen, 14076, France
Centre Hospitalier René Dubos
Cergy-Pontoise, 95300, France
Centre Jean Perrin
Clermont-Ferrand, 63011, France
Centre Léonard de Vinci
Dechy, 59187, France
Centre Georges François Leclerc
Dijon, 21079, France
Centre Hospitalier Départemental de Vendée
La Roche-sur-Yon, 85925, France
Centre Oscar Lambret
Lille, 59020, France
Centre de Pharmacovigilance
Lille, 59045, France
Centre Hospitalier de Bretagne Sud
Lorient, 56322, France
Centre Léon Bérard
Lyon, 69008, France
Institut Paoli Calmettes
Marseille, 13273, France
CHRU La Peyronie et Centre Val d'Aurelle
Montpellier, 34298, France
Centre Catherine de Sienne
Nantes, 44202, France
Centre Antoine Lacassagne
Nice, 06189, France
Institut Curie
Paris, 75005, France
Hôpital Saint-Louis
Paris, 75010, France
Hôpital Cochin
Paris, 75014, France
Hôpital Tenon
Paris, 75020, France
Centre Hospitalier Lyon-Sud
Pierre-Bénite, 69310, France
Institut Jean Godinot
Reims, 51056, France
Polyclinique de Courlancy
Reims, 51100, France
Centre Eugene Marquis
Rennes, 35042, France
Centre Henri Becquerel
Rouen, 76038, France
Clinique Radiologique
Saint-Brieuc, 22015, France
Centre René Huguenin
Saint-Cloud, 92210, France
Centre René Gauducheau
Saint-Herblain, 44805, France
Centre Paul Strauss
Strasbourg, 67065, France
Institut Claudius Régaud
Toulouse, 31052, France
Cabinet Dr Leroy
Tourcoing, 59200, France
Hôpital Bretonneau - Centre régional de cancérologie Henry Kaplan
Tours, 37000, France
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, 54511, France
Institut Gustave Roussy
Villejuif, 94805, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurence VANLEMMENS, MD
Centre Oscar Lambret
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2011
First Posted
January 2, 2012
Study Start
December 14, 2010
Primary Completion
September 28, 2015
Study Completion
September 28, 2015
Last Updated
April 3, 2018
Record last verified: 2018-03